September 28, 2016 3:45 PM ET

Biotechnology

Company Overview of BioMarker Pharmaceuticals, Inc.

Key Executives for BioMarker Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Charles Garvin J.D.1 RelationshipsChief Executive Officer--
Victor V. Vurpillat Ph.D., MBA15 RelationshipsCo-Founder, Vice President of Corporate Affairs and Director--
Xi Zhao-Wilson Ph.D., MBA10 RelationshipsCo-Founder and Chairperson--

BioMarker Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Xi Zhao-Wilson Ph.D., MBA 10 RelationshipsBioMarker Pharmaceuticals, Inc.--
Victor V. Vurpillat Ph.D., MBA 15 RelationshipsBioMarker Pharmaceuticals, Inc.--
Michael D. West Ph.D. 54 RelationshipsBioTime, Inc.63
Andrzej Bartke Ph.D. 10 RelationshipsBioMarker Pharmaceuticals, Inc.--
Gerold Grodsky Ph.D. 10 RelationshipsBioMarker Pharmaceuticals, Inc.--
View All Board Members

BioMarker Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.7K
Bonus
264.0K
Total Short Term Compensation
479.1K
Total Value of Options
33.3M
Compensation as of Fiscal Year
BioMarker Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Mark Mcpartland to Resign as Vice President of Corporate Development and Communications of Stellar Biotechnologies, Inc, Effective September 29, 2016
September 27, 2016 8:30 PM ET
Xenon Pharmaceuticals Inc. Appoints Dawn Svoronos to its Board of Directors
September 27, 2016 8:10 PM ET
Acceleron Pharma, Inc. Announces Management Changes, Effective from December 1, 2016
September 27, 2016 8:07 PM ET
Viropro Inc. Announces Resignation of Kenneth Sorensen as Board of Director
September 27, 2016 4:32 PM ET
Insmed Incorporated Appoints Roger Adsett as Chief Commercial Officer
September 27, 2016 12:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioMarker Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.